Custom application from SAS streamlines analysis, linking dynamic graphics, statistical details CARY, NC (Mar. 01, 2011) - JMP® Clinical 3, just released by business analytics leader SAS, offers new ...
Investing.com - Citizens JMP has reiterated its Market Outperform rating and $5.00 price target on Sana Biotechnology (NASDAQ:SANA) following updated clinical data from its diabetes treatment program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback